Literature DB >> 348459

Metabolism and mutagenicity of halogenated olefins--a comparison of structure and activity.

D Henschler.   

Abstract

Chlorinated ethylenes are metabolized in mammals, as a first step, to epoxides. The fate of these electrophilic intermediates may be reaction with nucleophiles (alkylation), hydrolysis, or intramolecular rearrangement. The latter reaction has been studied in the whole series of chlorinated epoxiethanes. The rearrangement products found were: acyl chlorides (tetrachloro-, trichloro-, and 1,1-dichloroethylenes), or chlorinated aldehydes (1,2-dichloroethylenes, cis- and trans-, vinyl chloride). The metabolities found in vivo are identical with, or further derivatives of these rearrangment products, with one important exception: trichloroethylene. With this compound, in vivo rearrangement yields chloral exclusively. The mechanism of the different rearrangement has been identified as a Lewis acid catalysis. All chlorinated ethylenes have been investigated in a tissue-mediated mutagenicity testing system. The prominent molecular feature of those with mutagenic effects (trichloro-, 1,1-dichloro-, and monochloroethylene) is unsymmetric chlorine substitution which renders the epoxides unstable, whereas symmetric substitution confers relative stability and nonmutagenic property.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 348459      PMCID: PMC1475339          DOI: 10.1289/ehp.772161

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  6 in total

1.  Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation.

Authors:  H Greim; G Bonse; Z Radwan; D Reichert; D Henschler
Journal:  Biochem Pharmacol       Date:  1975-11-01       Impact factor: 5.858

2.  Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium.

Authors:  H Bartsch; C Malaveille; R Montesano; L Tomatis
Journal:  Nature       Date:  1975-06-19       Impact factor: 49.962

3.  Chemical reactivity, metabolic oxirane formation and biological reactivity of chlorinated ethylenes in the isolated perfused rat liver preparation.

Authors:  G Bonse; T Urban; D Reichert; D Henschler
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

4.  Carcinogenicity of trichloroethylene: fact or artifact?

Authors:  D Henschler; E Eder; T Neudecker; M Metzler
Journal:  Arch Toxicol       Date:  1977-07-19       Impact factor: 5.153

5.  Human, rat and mouse liver-mediated mutagenicity of vinyl chloride in S. typhimurium strains.

Authors:  H Bartsch; C Malaveille; R Montesano
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

Review 6.  Chemical reactivity, biotransformation, and toxicity of polychlorinated aliphatic compounds.

Authors:  G Bonse; D Henschler
Journal:  CRC Crit Rev Toxicol       Date:  1976-10
  6 in total
  5 in total

1.  Complete degradation of tetrachloroethene by combining anaerobic dechlorinating and aerobic methanotrophic enrichment cultures.

Authors:  J Gerritse; V Renard; J Visser; J C Gottschal
Journal:  Appl Microbiol Biotechnol       Date:  1995-10       Impact factor: 4.813

2.  Induction of rat liver drug-metabolizing enzymes by tetrachloroethylene.

Authors:  N Hanioka; H Jinno; T Toyo'oka; T Nishimura; M Ando
Journal:  Arch Environ Contam Toxicol       Date:  1995-04       Impact factor: 2.804

3.  Trichloroethylene effects on the formation of enzyme-altered foci in rat liver.

Authors:  M M Milks; D Couri
Journal:  Arch Toxicol       Date:  1984-12       Impact factor: 5.153

Review 4.  Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

Authors:  D Krewski; J R Withey; L F Ku; M E Andersen
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

5.  Dechloriation mechanisms of chlorinated olefins.

Authors:  R A Van Dyke
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.